Trial intelligence / Profile preview

Vardenafil crossover pilot study in traumatic spinal cord injury-related erectile dysfunction

2004-005282-37Phase 4Completed

Sponsor
Bayer
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, double-blind trial of vardenafil in erectile dysfunction (ED) (2 arms), sponsored by Bayer. Primary endpoints: Characteristics of responders and non-responders at baseline and Duration of erection with rigidity greater than 70%. Started Jan 2006; status: completed.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on 2004-005282-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-005282-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call